Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-6-14
pubmed:abstractText
The regulation of transcriptional initiation in the human genome is a critical component of global gene regulation, but a complete catalog of human promoters currently does not exist. In order to identify regulatory regions, we developed four computational methods to integrate 129 sets of ENCODE-wide chromatin immunoprecipitation data. They collectively predicted 1393 regions. Roughly 47% of the regions were unique to one method, as each method makes different assumptions about the data. Overall, predicted regions tend to localize to highly conserved, DNase I hypersensitive, and actively transcribed regions in the genome. Interestingly, a significant portion of the regions overlaps with annotated 3'-UTRs, suggesting that some of them might regulate anti-sense transcription. The majority of the predicted regions are >2 kb away from the 5'-ends of previously annotated human cDNAs and hence are novel. These novel regions may regulate unannotated transcripts or may represent new alternative transcription start sites of known genes. We tested 163 such regions for promoter activity in four cell lines using transient transfection assays, and 25% of them showed transcriptional activity above background in at least one cell line. We also performed 5'-RACE experiments on 62 novel regions, and 76% of the regions were associated with the 5'-ends of at least two RACE products. Our results suggest that there are at least 35% more functional promoters in the human genome than currently annotated.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-10592259, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-11932250, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-12519945, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-12547512, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-12566409, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-14616058, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-14663149, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-15247917, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-15499007, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-15539566, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-15782207, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-15876366, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-16141072, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-16169926, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-16344566, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-16791208, http://linkedlifedata.com/resource/pubmed/commentcorrection/17567992-8120887
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1088-9051
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
720-31
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Integrated analysis of experimental data sets reveals many novel promoters in 1% of the human genome.
pubmed:affiliation
Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural